The Most Hated Man in America Martin Shkreli May Face New Charges

Grow Your Business, Not Your Inbox

Stay informed and join our daily newsletter now!
Will be used in accordance with our Privacy Policy
The Most Hated Man in America Martin Shkreli May Face New Charges
Image credit: Eduardo Munoz Alvarez / Stringer | Getty Images
Entrepreneur Staff
1 min read

Remember Martin Shkreli, the charming former CEO of Turing Pharmaceuticals, who jacked up the price of AIDS and cancer drug Daraprim from $13.50 to $750 a pill? When he appeared in U.S. District Court in Brooklyn today on existing fraud charges, it was revealed that he may face an additional indictment as well. (How the crowd didn't erupt into applause we don't quite understand.)

The details of the new indictment were not made public, but given that he was arrested last December on multiple charges of securities and wire fraud, we'll guess that they are nothing to be proud of.

RELATED: 5 PR Tips for Martin Shkreli AKA the 'Most-Hated Man' in America

Speaking to reporters, Shkreli's attorney Ben Brafman said in part, "I think today was a good day for Martin Shkreli." Really? It's "a good day" when you get new charges piled on your old charges? Oh Marty, we're glad this guy is your lawyer.
 
 

More from Entrepreneur

Get heaping discounts to books you love delivered straight to your inbox. We’ll feature a different book each week and share exclusive deals you won’t find anywhere else.
Jumpstart Your Business. Entrepreneur Insider is your all-access pass to the skills, experts, and network you need to get your business off the ground—or take it to the next level.
Starting, buying, or growing your small business shouldn’t be hard. Guidant Financial works to make financing easy for current and aspiring small business owners by providing custom funding solutions, financing education, and more.

Latest on Entrepreneur

Entrepreneur Media, Inc. values your privacy. In order to understand how people use our site generally, and to create more valuable experiences for you, we may collect data about your use of this site (both directly and through our partners). By continuing to use this site, you are agreeing to the use of that data. For more information on our data policies, please visit our Privacy Policy.